Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Seladelpar: New hope for patients with primary biliary cholangitis

Yulia A. Nevzorova,Francisco Javier Cubero

Med（2024）

Cited 0|Views6
No score
Abstract
The study by Hirschfield et al.1 demonstrated safety profile and clinically significant effectiveness of the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar in patients with primary biliary cholangitis, highlighting its plausible use as a second-line treatment to reduce disease activity and pruritus.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined